A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT02951533 · COMPLETED
Trial details
- NCT number
- NCT02951533
- Sponsor
- Janssen-Cilag G.m.b.H
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-12
- Primary completion
- 2017-09-13
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.